
### [MONDO:0012580](http://purl.obolibrary.org/obo/MONDO_0012580)
**Label:** hereditary pulmonary alveolar proteinosis

**Subclasses:** [MONDO:0012582](http://purl.obolibrary.org/obo/MONDO_0012582) (interstitial lung disease due to ABCA3 deficiency), [MONDO:0016323](http://purl.obolibrary.org/obo/MONDO_0016323) (chronic respiratory distress with surfactant metabolism deficiency), [MONDO:0018603](http://purl.obolibrary.org/obo/MONDO_0018603) (interstitial lung disease due to SP-c deficiency), [MONDO:0009929](http://purl.obolibrary.org/obo/MONDO_0009929) (neonatal acute respiratory distress due to SP-b deficiency), [MONDO:0010424](http://purl.obolibrary.org/obo/MONDO_0010424) (surfactant metabolism dysfunction, pulmonary, 4), [MONDO:0013712](http://purl.obolibrary.org/obo/MONDO_0013712) (surfactant metabolism dysfunction, pulmonary, 5), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0019979](http://purl.obolibrary.org/obo/GO_0019979) (interleukin-4 binding), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0022008](http://purl.obolibrary.org/obo/GO_0022008) (neurogenesis), [GO:0005771](http://purl.obolibrary.org/obo/GO_0005771) (multivesicular body), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0002532](http://purl.obolibrary.org/obo/GO_0002532) (production of molecular mediator involved in inflammatory response), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0097208](http://purl.obolibrary.org/obo/GO_0097208) (alveolar lamellar body), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0007585](http://purl.obolibrary.org/obo/GO_0007585) (respiratory gaseous exchange), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0097233](http://purl.obolibrary.org/obo/GO_0097233) (alveolar lamellar body membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- [GO:0097233](http://purl.obolibrary.org/obo/GO_0097233) (alveolar lamellar body membrane) 58.33%
- [GO:0097232](http://purl.obolibrary.org/obo/GO_0097232) (lamellar body membrane) 58.33%
- [GO:0097208](http://purl.obolibrary.org/obo/GO_0097208) (alveolar lamellar body) 58.33%
- [GO:0005771](http://purl.obolibrary.org/obo/GO_0005771) (multivesicular body) 58.33%
- [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome) 58.33%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 58.33%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 58.33%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- Thing 51.57%
- [GO:0042599](http://purl.obolibrary.org/obo/GO_0042599) (lamellar body) 43.69%
- [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 43.69%
- [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 43.69%
- [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 43.69%


